Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00338039Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2005
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in pancreatic cancer (PC), sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2005; status: completed.
02
Drugs
KL-140
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00338039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338039.